Risk-Stratified Transitional Care and Cardiovascular Hospitalizations by Sex: A Secondary Analysis of a - Scorecard - MDSpire

Risk-Stratified Transitional Care and Cardiovascular Hospitalizations by Sex: A Secondary Analysis of a

  • By

  • Douglas S. Lee

  • Chang (Nancy) Wang

  • Peter C. Austin

  • Sharon E. Straus

  • Michael E. Farkouh

  • Alice Chong

  • Monica Taljaard

  • Stephanie Poon

  • Stuart Smith

  • Robert S. McKelvie

  • Robert M. Iwanochko

  • Andrea MacDougall

  • Esam Elbarasi

  • Peter M. Cram

  • Jiming Fang

  • Clare L. Atzema

  • Jacob A. Udell

  • Paula A. Rochon

  • Michael J. Schull

  • Susanna Mak

  • Heather J. Ross

  • May 12, 2026

  • 0 min

Share

Clinical Scorecard: Sex-Based Analysis of Risk-Stratified Transitional Care and Cardiovascular Hospitalization Rates

At a Glance

CategoryDetail
Condition
Key MechanismsRisk stratification algorithm for acute HF management in emergency settings, including the EHMRG30-ST.
Target Population
Care Setting

Key Highlights

  • Heart failure affects over 64 million patients globally, with over 1 million hospitalizations annually in the US and Europe.

Guideline-Based Recommendations

Diagnosis

    Management

    • Implement the EHMRG30-ST algorithm for risk stratification and discharge planning, detailing its components.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Early discharge and outpatient follow-up can improve outcomes for low-risk patients, as evidenced by the COACH trial.

        Clinical Best Practices

        • Employ a multipronged strategy for risk assessment in emergency departments, as demonstrated in the COACH trial.

        References

        Original Source(s)

        Risk-Stratified Transitional Care and Cardiovascular Hospitalizations by Sex: A Secondary Analysis of a

        • by Douglas S. Lee, Chang (Nancy) Wang, Peter C. Austin, Sharon E. Straus, Michael E. Farkouh, Alice Chong, Monica Taljaard, Stephanie Poon, Stuart Smith, Robert S. McKelvie, Robert M. Iwanochko, Andrea MacDougall, Esam Elbarasi, Peter M. Cram, Jiming Fang, Clare L. Atzema, Jacob A. Udell, Paula A. Rochon, Michael J. Schull, Susanna Mak, Heather J. Ross

        • May 12, 2026

        Related Content

        The effectiveness and safety of oral Chinese patent medicines in treating myocardial infarction complicated with heart failure: a network meta-analysis of 12 interventions

        Beyond recovery: long-term cardiovascular risks after severe COVID-19 requiring intensive care

        Risk-score performance for detecting transthyretin cardiac amyloidosis in severe aortic stenosis: a prospective cohort study